Baselode Closes Bought Deal Financing

In This Article:

Toronto, Ontario--(Newsfile Corp. - February 14, 2024) - Baselode Energy Corp. (TSXV: FIND) (OTCQB: BSENF) ("Baselode" or the "Company") is pleased to announce the closing of its previously announced "bought deal" private placement (the "Offering") for aggregate gross proceeds of C$6,000,000, which includes the full exercise of the Underwriter's (as defined herein) over-allotment option for gross proceeds of C$1,000,000. Under the Offering, the Company sold the following:

  • 2,222,222 units of the Company (each, a "Unit") at a price of C$0.45 per Unit for gross proceeds of C$1,000,000 from the sale of Units; and

  • 7,692,308 flow-through units of the Company that were sold to charitable purchasers (each, a "Charity FT Unit", and collectively with the Units, the "Offered Securities") at a price of C$0.65 per Charity FT Unit for gross proceeds of C$5,000,000 from the sale of Charity FT Units.

Red Cloud Securities (the "Underwriter") acted as sole underwriter and bookrunner under the Offering.

Each Unit consists of one common share of the Company (each, a "Common Share") and one half of one Common Share purchase warrant (each whole warrant, a "Warrant"). Each Charity FT Unit consists of one common share of the Company and one half of one Warrant, each of which will be issued as a "flow-through share" within the meaning of the Income Tax Act (Canada) (the "Tax Act"). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$0.65 at any time on or before February 14, 2026.

Proceeds from the sale of Charity FT Units will be used to incur expenses that qualify as "Canadian exploration expenses" as defined in subsection 66.1(6) of the Tax Act and "flow-through critical mineral mining expenditures" incurred pursuant to an exploration plan that primarily targets "critical minerals", each as defined in subsection 127(9) of the Tax Act. Such expenses will be renounced to the subscribers with an effective date not later than December 31, 2024, in the aggregate amount of not less than the total amount of gross proceeds raised from the issue of Charity FT Units.

In accordance with National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), 5,538,462 Charity FT Units (collectively, the "LIFE Offered Securities") were sold to purchasers resident in Canada pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the "Listed Issuer Financing Exemption"). The common shares of the Company issuable from the sale of these LIFE Offered Securities are immediately freely tradeable under applicable Canadian securities legislation.